玻璃化市場：按產品類型、應用、最終用戶和地區分類

2024 年全球玻璃化市場規模估計為 93 億美元，預計 2031 年將達到 265.1 億美元，2024 年至 2031 年的複合年成長率為 16.1%。

圖。

由於全球對輔助生殖技術（ART）的需求不斷增加，全球玻璃化冷凍市場正在穩步成長。玻璃化冷凍是一種先進的冷卻技術，用於冷凍和保存人類卵子、胚胎和卵巢組織以進行體外受精。該過程使生物樣本極其迅速地冷卻成玻璃狀固體，而不會形成結晶，從而保持其活力。由於不孕不育率的上升、用於治療不孕不育的醫療旅遊基礎的擴大、以及與傳統慢速冷凍技術相比玻璃化冷凍試管受精週期的成功率的提高，預計未來十年全球玻璃化冷凍市場將以顯著的速度成長。

市場動態：

全球玻璃化冷凍市場的發展受到全球不孕症盛行率上升的推動。根據世界衛生組織估計，到2023年4月，全球將有約4,800萬夫婦遭受不孕症問題的困擾。此外，生育延遲、壓力增加、肥胖、性行為感染傳染病和其他生活方式因素也導致不孕率上升。例如，根據美國國家醫學圖書館 2022 年 2 月的報告，15 個歐洲國家透過公共醫療保險完全或部分涵蓋 IVF 週期。然而，玻璃化冷凍的高成本、對人體組織冷凍保存的倫理問題以及發展中地區的認知度低是限制該技術廣泛應用的一些因素。此外，對提供生育治療的醫療機構的嚴格規定也給市場相關人員帶來了挑戰。隨著持續的研究和開發專注於開發更有效率的玻璃化解決方案，市場預計將迎來豐厚的利潤機會。市場領導正在投資開放和封閉玻璃化系統以及更好的冷凍保護劑等技術，以提高玻璃化循環的成功率。低成本國家醫療旅遊業的發展和新興經濟體可支配收入的提高將在未來幾年進一步推動對 ART 的需求。

本研究的主要特點

本報告對全球玻璃化治療市場進行了詳細分析，並展示了預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%），以 2023 年為基準年。

它揭示了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。

全球玻璃化市場的主要企業根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行分析。

研究中介紹的主要企業包括 Vitrolife AB、CooperSurgical, Inc.、Merck KGaA、Ferring Pharmaceuticals、Igenomix、Genea Biomedx、Cryoport, Inc.、Kitazato Corporation、ReproTech, LLC、Thermo Fisher Scientific、EMD Serono、OvaScience, Inc., 清零組合、Medline Inc. 和

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球玻璃化市場報告涵蓋該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員將透過用於分析全球玻璃化市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 限制因素
• 機會
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• PORTER 分析
• 併購情景
• 產業趨勢

4. 2019 年至 2031 年全球玻璃化市場（依產品類型）

• 玻璃化溶液
• 玻璃化冷凍設備
• 其他產品類型

5. 全球玻璃化市場，依應用，2019 年至 2031 年

• 體外受精（IVF）
• 幹細胞保存
• 其他應用

6. 全球玻璃化市場，依最終用戶分類，2019 年至 2031 年

• 不孕不育診所
• 醫院和診斷中心
• 研究組織
• 生物庫
• 其他

7. 2019 年至 2031 年全球玻璃化市場（按地區）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• Vitrolife AB
• CooperSurgical, Inc.
• Merck KGaA
• Ferring Pharmaceuticals
• Igenomix
• Genea Biomedx
• Cryoport, Inc.
• Kitazato Corporation
• ReproTech, LLC
• Thermo Fisher Scientific
• EMD Serono
• OvaScience, Inc.
• LifeGlobal
• Medline Industries, Inc.
• Reproductive Health Technologies

第 9 章分析師建議

• 命運之輪
• 分析師觀點
• 一致的機會圖

第10章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

The global vitrification market is estimated to be valued at USD 9.30 Bn in 2024 and is expected to reach USD 26.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.1% from 2024 to 2031.

Figure. Vitrification Market Share (%), By Region 2024

The global vitrification market is witnessing a steady growth owing to rising demand for assisted reproductive technologies (ART) across the globe. Vitrification is an advanced cooling technique used for cryopreservation of human eggs, embryos, and ovarian tissue during IVF procedures. This process involves extremely rapid cooling of biological samples to glassy solidity without any ice crystal formation, thereby preserving viability. With rising infertility rates, expanding base of medical tourism for fertility treatments, and improving success rates of vitrified IVF cycles compared to conventional slow freezing techniques, the global vitrification market is estimated to grow at a significant pace over the next decade.

Market Dynamics:

The global vitrification market is driven by rising prevalence of infertility worldwide. In April 2023, according to WHO, around 48 million couples globally suffered from infertility issues. Additionally, delaying parenthood, increasing stress levels, obesity, sexually transmitted diseases, and other lifestyle factors are contributing to higher infertility rates. For instance, yn February 2022, according to the National Library of Medicine, 15 European nations provide full or partial coverage of IVF cycles under public health insurance. However, high cost of vitrification procedure, ethical concerns regarding cryopreservation of human tissues, and lack of awareness in developing regions are some of the factors restricting broader adoption of this technology. Moreover, stringent regulations for health facilities providing fertility treatments pose challenges for market players. With ongoing R&D focusing on developing more efficient vitrification solutions, the market is expected to witness lucrative opportunities. Market leaders are investing in technologies such as open versus closed vitrification systems and better cryoprotectants to improve success rates of vitrified cycles. Increasing medical tourism in low-cost countries and rising disposable income in developing nations will further support the demand for ART in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global vitrification market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vitrification market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Vitrolife AB, CooperSurgical, Inc., Merck KGaA, Ferring Pharmaceuticals, Igenomix, Genea Biomedx, Cryoport, Inc., Kitazato Corporation, ReproTech, LLC, Thermo Fisher Scientific, EMD Serono, OvaScience, Inc., LifeGlobal, Medline Industries, Inc., and Reproductive Health Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vitrification market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vitrification market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Vitrification Solutions
  • Vitrification Equipment
  • Other Related Products
• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • In Vitro Fertilization (IVF)
  • Stem Cell Preservation
  • Other Applications
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Fertility Clinics
  • Hospitals and Diagnostic Centers
  • Research Institutes
  • Biobanks
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Key Players Insights
  • Vitrolife AB
  • CooperSurgical, Inc.
  • Merck KGaA
  • Ferring Pharmaceuticals
  • Igenomix
  • Genea Biomedx
  • Cryoport, Inc.
  • Kitazato Corporation
  • ReproTech, LLC
  • Thermo Fisher Scientific
  • EMD Serono
  • OvaScience, Inc.
  • LifeGlobal
  • Medline Industries, Inc.
  • Reproductive Health Technologies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Vitrification Market, By Product Type
  • Global Vitrification Market, By Application
  • Global Vitrification Market, By End User
  • Global Vitrification Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Vitrification Market, By Product Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Vitrification Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Vitrification Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Related Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Vitrification Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• In Vitro Fertilization (IVF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Stem Cell Preservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Vitrification Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Fertility Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospitals and Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biobanks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Vitrification Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Vitrolife AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperSurgical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ferring Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Igenomix
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genea Biomedx
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cryoport, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kitazato Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ReproTech, LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EMD Serono
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OvaScience, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LifeGlobal
• Medline Industries, Inc.
• Reproductive Health Technologies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us